Rejuvenate Biomed

#AI / data analytics / healthtech / informatics #Artificial intelligence (AI) #Drug repurposing #Partnership #Rejuvenate Biomed

Rejuvenate Bio and SAS to develop drug repurposing tool

Biotechnology company Rejuvenate Biomed has announced a partnership with analytics company SAS to develop a drug repurposing discovery tool to help researchers and scientists uncover medically relevant insights about drugs, diseases, and biological networks. The tool will be developed using SAS’ artificial intelligence (AI) and data… Read More

#Business & Investment #News

Age-related weak muscles
#Ageing #Rejuvenate Biomed #Sarcopenia

Advancing therapeutics to delay the onset of age-related diseases  

Rejuvenate Biomed, a clinical-stage company advancing therapeutics to delay the onset of age-related diseases, has completed a six-week clinical proof-of-mechanism study with lead candidate RJx-01 for the treatment of sarcopenia.   Sarcopenia is a musculoskeletal disease characterised by the progressive loss of skeletal muscle strength and mass,… Read More

#News